Prior to joining Rezolute in 2017 as a founding member of the management team, Dr. Roberts directed clinical development at Fibrogen, Inc., where he helped successfully launch and execute the global Phase 3 program and pharmaceutical partnership for a novel oral therapy for anemia associated with kidney disease, concluding the largest Phase 3 program ever conducted in CKD anemia, and resulting in global NDA filings and approvals. During Dr. Roberts’ tenure, Fibrogen achieved the largest biotech IPO in the previous 10 years.
From 2007 until 2012 Dr. Roberts held clinical development positions of increasing responsibility at Cymabay, Inc., where he developed novel therapies for metabolic diseases such as diabetes, dyslipidemia, NASH, and gout. His program and clinical leadership from IND through clinical proof-of-concept helped secure a global licensing and co-development agreement with a major pharmaceutical partner for a novel diabetes therapy, as well as the successful filing of a NDA for Seladelpar.
He is an inventor or author on more than 25 patents and publications in the fields of Endocrinology and Metabolism. Dr. Roberts received his B.S. in biochemistry from the University of California, San Diego and his M.D. Magna Cum Laude from Georgetown University. He completed a residency in Internal Medicine and a fellowship in Endocrinology at Stanford University Medical Center, where he also now serves as an Adjunct Associate Professor in the Division of Endocrinology.
What is Brian Kenneth Roberts' net worth?
The estimated net worth of Brian Kenneth Roberts is at least $150.35 thousand as of June 25th, 2025. Roberts owns 15,500 shares of Rezolute stock worth more than $150,350 as of December 5th. This net worth approximation does not reflect any other assets that Roberts may own. Additionally, Roberts receives a salary of $738,860.00 as Insider at Rezolute. Learn More about Brian Kenneth Roberts' net worth.
How old is Brian Kenneth Roberts?
Roberts is currently 49 years old. There are 2 older executives and no younger executives at Rezolute. The oldest executive at Rezolute is Mr. Nevan Charles Elam J.D., Founder, CEO & Acting Chairman of the Board, who is 57 years old. Learn More on Brian Kenneth Roberts' age.
What is Brian Kenneth Roberts' salary?
As the Insider of Rezolute, Inc., Roberts earns $738,860.00 per year. The highest earning executive at Rezolute is Mr. Nevan Charles Elam J.D., Founder, CEO & Acting Chairman of the Board, who commands a salary of $973,650.00 per year. Learn More on Brian Kenneth Roberts' salary.
How do I contact Brian Kenneth Roberts?
Has Brian Kenneth Roberts been buying or selling shares of Rezolute?
Brian Kenneth Roberts has not been actively trading shares of Rezolute in the last ninety days. Most recently, on Wednesday, June 25th, Brian Kenneth Roberts bought 2,500 shares of Rezolute stock. The stock was acquired at an average cost of $4.38 per share, with a total value of $10,950.00. Following the completion of the transaction, the insider now directly owns 15,500 shares of the company's stock, valued at $67,890. Learn More on Brian Kenneth Roberts' trading history.
Who are Rezolute's active insiders?
Are insiders buying or selling shares of Rezolute?
During the last twelve months, Rezolute insiders bought shares 10 times. They purchased a total of 1,299,405 shares worth more than $4,256,190.31. The most recent insider tranaction occured on June, 25th when insider Brian Kenneth Roberts bought 2,500 shares worth more than $10,950.00. Insiders at Rezolute own 14.8% of the company.
Learn More about insider trades at Rezolute. Information on this page was last updated on 6/25/2025.
